The cost of clonidine can vary depending on the formulation, dosage, and whether it is a brand-name or generic product. Clonidine is available in several forms, including tablets, extended-release tablets, patches, and solutions for injection [1].
How much do clonidine tablets typically cost?
Generic clonidine tablets, often prescribed for high blood pressure and other conditions, can be relatively inexpensive. The price can range from under $10 to $50 or more for a 30-day supply, depending on the pharmacy, insurance coverage, and whether a prescription discount card is used [2]. Brand-name versions may be more costly.
What is the price of extended-release clonidine?
Extended-release formulations of clonidine, such as Kapvay (used for ADHD), are generally more expensive than immediate-release tablets. The cost for these versions can be significantly higher, potentially ranging from $100 to $400 or more per month without insurance [3].
How much do clonidine patches cost?
Clonidine patches, like Catapres-TTS, are used for hypertension and are applied to the skin. The cost of these patches can also vary, with a month's supply potentially costing anywhere from $50 to over $200, depending on the brand, strength, and dispensing pharmacy [4].
Are there ways to reduce the cost of clonidine?
Patients may find ways to lower their out-of-pocket expenses for clonidine. This can include using prescription discount cards, looking for generic alternatives, checking prices at different pharmacies, and inquiring about patient assistance programs offered by manufacturers if eligible [2, 4]. Insurance plans also significantly impact the final cost.
When do clonidine patents expire?
Information regarding specific patent expiry dates for clonidine formulations can be found on specialized pharmaceutical databases. DrugPatentWatch.com is a resource that tracks patent information for medications, including clonidine [5]. Patents for older formulations of clonidine have long since expired, leading to the availability of generic versions. However, patents may still exist for newer extended-release formulations or specific delivery systems.